BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.71 USD 1.05% Market Closed
Market Cap: 1.6B USD

Intrinsic Value

The intrinsic value of one BCRX stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.71 USD, BioCryst Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BCRX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
BioCryst Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

BCRX looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BCRX is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BCRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BCRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BioCryst Pharmaceuticals Inc.

Explain Valuation
Compare BCRX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BCRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioCryst Pharmaceuticals Inc

Current Assets 355.7m
Cash & Short-Term Investments 212.9m
Receivables 91.3m
Other Current Assets 51.5m
Non-Current Assets 90.7m
Long-Term Investments 39.7m
PP&E 19.2m
Other Non-Current Assets 31.8m
Current Liabilities 190.2m
Accounts Payable 5.6m
Accrued Liabilities 119.1m
Other Current Liabilities 65.5m
Non-Current Liabilities 644.1m
Long-Term Debt 635.2m
Other Non-Current Liabilities 8.9m
Efficiency

Free Cash Flow Analysis
BioCryst Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioCryst Pharmaceuticals Inc

Revenue
599.8m USD
Cost of Revenue
-15.7m USD
Gross Profit
584.1m USD
Operating Expenses
-508m USD
Operating Income
76.1m USD
Other Expenses
-84.9m USD
Net Income
-8.8m USD
Fundamental Scores

BCRX Profitability Score
Profitability Due Diligence

BioCryst Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROIC
ROIC is Increasing
Exceptional Gross Margin
hidden
Profitability
Score

BioCryst Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BCRX Solvency Score
Solvency Due Diligence

BioCryst Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

BioCryst Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BCRX Price Targets Summary
BioCryst Pharmaceuticals Inc

Wall Street analysts forecast BCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCRX is 21.23 USD with a low forecast of 9.09 USD and a high forecast of 33.6 USD.

Lowest
Price Target
9.09 USD
18% Upside
Average
Price Target
21.23 USD
175% Upside
Highest
Price Target
33.6 USD
336% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

BioCryst Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BCRX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BCRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BCRX stock?

The intrinsic value of one BCRX stock under the Base Case scenario is hidden USD.

Is BCRX stock undervalued or overvalued?

Compared to the current market price of 7.71 USD, BioCryst Pharmaceuticals Inc is hidden .

Back to Top